Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Darglitazone is a TZD (thiazolidinedione) that increases the sensiticirt od clls to insulin, stimulating insulin-induced P13K activity at submicromolar concentrations. It increases insulin effectiveness in diabetes mellitus subjects.